Comment on Hayman Capital's Kyle Bass Vows to Continue Drug-Patent Challenges

Hayman Capital's Kyle Bass Vows to Continue Drug-Patent Challenges

Despite recent setbacks, hedge-fund manager Kyle Bass says he’ll keep trying to invalidate what he calls weak pharmaceutical patents.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News